Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

UPDATE 1-Debt-laden Carillion secures deal to sell part of UK healthcare unit

Published 2017-12-13, 03:25 a/m
© Reuters.  UPDATE 1-Debt-laden Carillion secures deal to sell part of UK healthcare unit
SRP
-
CLLN
-

(Adds details, share movement)

Dec 13 (Reuters) - Troubled British construction firm Carillion CLLN.L said on Wednesday it had reached a deal to sell a large part of its UK healthcare facilities management business to outsourcing group Serco SRP.L , helping it cut its debt by 41.4 million pounds.

The company's shares, which have slumped more than 90 percent since a profit warning in July, rose as much at 10 percent in early trade on Wednesday. They traded at 18 pence at 0813 GMT. which has said it was heading towards a breach of debt covenants and needed fresh capital, had said it would exit its UK healthcare and Canadian businesses to help raise more than 300 million pounds by the end of 2018 from disposals. sale, for about 47.7 million pounds ($63.55 million), includes a portfolio of healthcare facilities management contracts and related ancillary contracts and assets. The firm said 15 sites would be transferred to Serco on a phased basis.

The firm had said in September said it intended to exit the business and then announced it had a preliminary agreement for selling a large part of it to Serco for 50.1 million pounds.

Carillion said net disposal proceeds of 41.4 million pounds would be used to prepay of part of a 140 million pound credit.

"I am pleased we have been able to successfully conclude this transaction which will contribute to our efforts to reduce net debt," Carillion's Interim CEO Keith Cochrane said.

Analysts estimate Carillion's debts including provisions, pensions and accounts payable at about 1.5 billion pounds.

Carillion is fighting for its survival after costly contract delays and a downturn in new business at the company, which handles major infrastructure projects for the British and other governments. Its CEO quit in July and it issued its third profit warning in five months in November. & Co is acting as lead financial adviser and sponsor to Carillion for the healthcare unit sale.

($1 = 0.7506 pounds)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.